Thanks to countless medicines in development, there is hope on the horizon to take down diseases of all kinds. From mental illness to cancer, researchers are advancing our knowledge of how these diseases operate and developing new approaches and treatments to fight back.
LATEST ARTICLES
-
Speeding Innovation with AI and Big Data
Biopharmaceutical researchers are using AI to cut the time and costs it takes to manually sift through datasets.
-
What's Next? Discovery, Treatments and Cures in the Biopharmaceutical Pipeline
For many patients, the biopharmaceutical pipeline is their best hope for a cure or a longer, healthier life.
-
Research Doesn’t End On A Medicine’s Approval
Research on a medicine doesn't end on the initial approval by the FDA. Eli Lilly and Company's chief medical officer shares why ongoing research helps us better understand a medicine's full value.
-
Cumulative Steps, Big Gains for Patients
Advances in treating debilitating diseases are often not the result of one single breakthrough, but rather an accumulation of knowledge and research over time.
-
How the War on Cancer is Evolving
The progress we have made may only foreshadow a much more intensive fight against cancer that is likely to be characterized by small steps towards a cure and efforts to improve quality of life rather than focus on big breakthroughs alone.
RELATED ARTICLES
How America's Biopharmaceutical Companies Lead in New Medicine Development
From advanced biologics to transformative therapies, such as cell and gene therapy, recent advancements have revolutionized our ability to treat, and in some cases cure, some of the most challenging diseases.
This Scientist Is Working to Develop a Potential COVID-19 Vaccine
Janssen is one among dozens of biopharmaceutical companies working around the clock to identify and develop safe and effective vaccines to prevent COVID-19.
How Intellectual Property Protections Spur Innovation
Strong IP protections are critical to safeguarding innovation within the biopharmaceutical industry.
By the Numbers: Vaccines and Treatments in Development for COVID-19
America's biopharmaceutical companies are committed to developing solutions to help diagnose, treat and prevent COVID-19.
World AIDS Day 2019, Hope for the Future
With over 50 medicines and vaccines for HIV in development, patients have reason to be hopeful.
Battling Disease with Cell and Gene Therapy
Cell and gene therapies can often sound like science fiction. But their possibilities represent a new era of medicine.
Researcher Profile: Jim Martinez, MD
Promising results from clinical trials of CGRP inhibitors bring renewed hope for patients with cluster headache.
Washington is considering policy changes that could threaten innovation
New policy proposals in Washington threaten to hamstring investment in innovation and jeopardize breakthroughs.
Researcher Profile: Roland Kolbeck
Dr. Kolbeck led a team of researchers to develop what has become AstraZeneca’s first respiratory biologic treatment.
Researcher Profile: Dr. Marie-Claire Peakman
Dr. Marie-Claire Peakman always knew she wanted to make a difference in the world.
A New Era In Treatments For Migraine
Reducing unnecessary suffering resulting from migraine is beneficial to both individual patients and to society.
A New Era in Cervical Cancer Treatment
January is Cervical Cancer Awareness Month. Every day, scientists continue to research new ways to treat and prevent cervical cancer in an effort to push the death rate down to zero.
Tackling Neurological Disorders in New Ways
Chronic pain. Alzheimer's disease. Multiple Sclerosis. Brain tumors. These are some of the most well-known and prevalent diseases afflicting the more than 100 million Americans who are impacted by a neurological disorder.
Researcher Profile: Andrea Fanjul
For Dr. Andrea Fanjul and a team of scientists at Takeda, it’s the patients and their stories that bring purpose to their work.
Researcher Profile: Christina Kiley
Through her roles at Eli Lilly and Company, Dr. Christina Kiley developed a strong understanding of the patient perspective and the diverse ways patients are incorporated into biopharmaceutical research.
Breast Cancer Awareness Month: The Fight for New Treatments Continues
October is Breast Cancer Awareness Month, which each year calls attention to the condition that one in every eight women will face throughout their lifetimes.
Why Has Research into Alzheimer's Disease Been So Hard?
Why, when we have seen such progress in our ability to treat other diseases, such as cancer, diabetes and HIV, has progress in Alzheimer's research been so difficult to achieve?
Vaccines: Cutting Health Care Costs While Saving Countless Lives
In the United States, 16 diseases are now preventable as a result of childhood vaccines, resulting in an estimated $1.4 trillion in societal costs saved.
Destroying the Cancer Threat
It is sometimes said that after a researcher has studied one cancer patient, he or she is left with the understanding of exactly one cancer patient.
Tackling Neurological Disorders in New Ways
Chronic pain. Alzheimer's disease. Multiple Sclerosis. Brain tumors. These are some of the most well-known and prevalent diseases afflicting the more than 100 million Americans who are impacted by a neurological disorder.
Breaking Through Depression
The latest treatments for mental illness are helping patients live more fulfilling lives.
Rare Disease by the Numbers
Today is Rare Disease Day, which serves as a time to recognize the more than 30 million Americans living with some type of rare disease.
Researcher Profile: Wayne Drevets
Dr. Drevets is a scientist at Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, where he oversees the development of new treatments for mood disorders, such as major depressive disorder, treatment resistant depression and suicidality.
Researcher Profile: Brian Johns
Dr. Brian Johns is currently the vice president of HIV Research at GlaxoSmithKline (GSK), where he leads a team of 24 biopharmaceutical researchers to investigate new ways of treating and preventing HIV/AIDS.
Today Is World AIDS Day, A Moment to Remember How Far We’ve Come
Today, a 20-year-old with HIV can expect to live to the age of 70. Few diseases have seen similar progress, and it's somewhat astounding to see that in just over 30 years, HIV has gone from a death sentence to a chronic medical condition.
Innovations in Mental Health
Nearly one in five American adults experience some form of mental illness in any given year. America's biopharmaceutical companies are working to develop medicines that help reduce these diseases into manageable conditions.
Improving Access to Treatment: Peggy Symons
Peggy Symons lives every single day advocating for more and better access to medications, not only for herself but for everyone living with schizophrenia and their families.
Fighting for Reform: The Honorable Steven Leifman
The Honorable Steven Leifman worked to transform the criminal justice system of Florida to better help - not hinder - the treatment of mental health inmates in Southern Florida.
Rethinking Psychiatric Treatment: Dr. Husseini Manji
Today, Dr. Husseini Manji is the global therapeutic head for neuroscience at Janssen. In this role, he has researched the ways in which psychiatric disorders alter a patient’s cellular systems, resulting in symptoms or negative behaviors.
A Major Blood Cancer: Leukemia
Thanks to the work of biopharmaceutical researchers, newly developed medicines that can target cancer at the molecular level are helping blood cancer patients turn the corner.
A Critical Quest: Working Toward Better Treatments for Brain Cancer
Glioblastoma is the most aggressive form of brain cancer, and one that impacts more than 12,000 Americans each year.
A Pipeline of Promise: Immuno-oncology
We are in a new era of medicine, powered in part by the advancements and innovations being made in the field of immuno-oncology or immunotherapy
More Than 240 Immuno-oncology Treatments in Development to Fight Cancer
The need for new cancer treatments is more important than ever, and America's biopharmaceutical companies are boldly leading the way in discovering new breakthroughs.
Researching Melanoma: Progress Emerging from Years of Setbacks
Between 1998 and 2014, there were 96 unsuccessful drugs and 7 approved drugs for melanoma.
High Cholesterol: Meeting Unmet Need for A Deadly Chronic Condition
The introduction of statin therapy nearly 30 years ago transformed the treatment of high cholesterol for many patients, yet some continued to face challenges. Advances over the past decade have provided important treatment options for these patients.
A New Way to Fight Cancer
It used to be science fiction. Harnessing your body's own immune system to fight cancer. But what was once the fruit of a wild imagination is today a reality.
A Veteran's Victory Over Cancer
Within a year of retiring from the Air Force in 2003, Corneliussen-James "C.J." was diagnosed with stage 2 breast cancer, joining one-in-eight American women who will be diagnosed with breast cancer in their lifetime.
Helping Diabetes Patients Thrive
Diabetes is a serious condition that effects more than 30 million Americans. While complications of the disease can be dire, there is hope.
